Kyverna Therapeutics, Inc. - KYTX

Insiders (Form 4) · last 180 days · showing up to 200 transactions · Form 144 is shown in the SEC filings tab · Updating…
Visible: 0
Transaction codes: P = Open-market purchase · S = Open-market sale · A = Grant/award · M = Exercise/conversion of derivative · G = Gift · F = Tax withholding · J = Other · A/D: A = Acquired (buy/receive) · D = Disposed (sell/give)
Filed Owner Title Code A/D Shares Price Value Shares after SEC
Mar 17, 2026 Chief Executive Officer A A 350,000.0 0.0 0.0 350,000.0 View
Mar 17, 2026 Chief Executive Officer A A 58,000.0 0.0 0.0 58,000.0 View
Mar 17, 2026 Chief Financial Officer A A 65,000.0 0.0 0.0 65,000.0 View
Mar 17, 2026 Chief Financial Officer A A 10,000.0 0.0 0.0 10,000.0 View
Mar 17, 2026 See Remarks A A 105,000.0 0.0 0.0 105,000.0 View
Mar 17, 2026 See Remarks A A 18,000.0 0.0 0.0 18,000.0 View
Mar 04, 2026 A A 42,945.0 0.0 0.0 42,945.0 View
Mar 04, 2026 A A 11,006.0 0.0 0.0 11,006.0 View
Feb 26, 2026 A A 42,945.0 0.0 0.0 42,945.0 View
Feb 26, 2026 A A 11,006.0 0.0 0.0 11,006.0 View
Feb 11, 2026 Chief Technology Officer A A 300,000.0 0.0 0.0 300,000.0 View
Jan 14, 2026 Executive Chairperson A A 185,000.0 0.0 0.0 185,000.0 View
Jan 14, 2026 Executive Chairperson A A 24,301.0 0.0 0.0 70,935.0 View
Jan 14, 2026 Executive Chairperson A A 30,000.0 0.0 0.0 46,634.0 View
Dec 22, 2025 P A 133,333.0 7.5 999,997.5 869,317.0 View
Dec 22, 2025 P A 133,333.0 7.5 999,997.5 869,317.0 View
Dec 17, 2025 Chief Technology Officer M D 23,998.0 0.0 0.0 85,865.0 View
Dec 17, 2025 Chief Technology Officer S D 23,998.0 12.2 292,775.6 22,636.0 View
Dec 17, 2025 Chief Technology Officer M A 23,998.0 4.83 115,910.34 46,634.0 View